Fagron Compounding Services LLC dba Fagron Sterile Services recalls Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per packag…
- Recall date
- June 29, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0910-2018
- FDA classification
- Class I
- Brand / firm
- Fagron Compounding Services LLC dba Fagron Sterile Services
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-02.
Get recall alerts
Free email alert whenever Fagron Compounding Services LLC dba Fagron Sterile Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fagron Compounding Services LLC dba Fagron Sterile Services